Evidence map›Paper›PMID 41024941›Full record

ArticleJournal of kidney cancer and VHL2025

Expression of Follicle-Stimulating Hormone Receptor in Von Hippel-Lindau Associated Tumors and Cysts: An Immunohistochemical Study.

Nicolae Ghinea, Maximilian Frosch, Anne Couvelard, Sefer Elezkurtaj, Vinciane Rebours, Philippe Camparo, Bertrand Guillonneau, Christine Julia Gizaw, Jan-Helge Klingler

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of kidney cancer and VHL, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicolae GhineaInstitut National de la Santé et de la Recherche Médicale, Paris, France.
Maximilian FroschInstitute of Neuropathology, University of Freiburg, Faculty of Medicine, Germany.
Anne CouvelardHôpital Bichat, Service de Pathologie, 46 rue Henri-Huchard, 75018 Paris.
Sefer ElezkurtajInstitut für Pathologie Charité, Universitätmedizin Berlin; Campus Charité Mitte, Charitéplatz 1,10117 Berlin.
Vinciane ReboursHôpital Beaujon, Service de Pancréatologie, 100 Boulevard du général Leclerc, 92110-Clichy, France.
Philippe CamparoI-patH, 11 Allée de l'échauguette, 80000 Amiens, France.
Bertrand GuillonneauSektionleiter uro-onkologische Chirurgie Klinik für Urologie Charité Universitätmedizin Berlin, Charitéplatz 1,10117 Berlin, Germany.
Christine Julia GizawDepartment of Neurosurgery, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Germany France.
Jan-Helge KlinglerDepartment of Neurosurgery, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Germany France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Von Hippel-Lindau (VHL) disease is a hereditary condition caused by mutations in the

Indexed as

ccRCCCNS-HemangioblastomaKidney CancerpanNETVHL

Identifiers

PMID41024941
PMCPMC12476826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.